Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Brazil.
J Periodontal Res. 2018 Jun;53(3):315-323. doi: 10.1111/jre.12516. Epub 2017 Nov 6.
Comprehension of the similarities and differences in the composition of the subgingival microbiota of patients with diabetes mellitus (DM), smokers or smokers with DM is an important step in developing therapies specific for these groups at risk for periodontitis. Therefore, the aim of this study was to compare the combined and individual effects of DM and smoking on the levels and prevalence of key subgingival periodontal pathogens in patients with chronic periodontitis.
One hundred patients with generalized chronic periodontitis were allocated into one of the following groups: DM (n = 25, non-smokers with type 2 DM); S (n = 25, non-diabetic smokers); SDM (n = 25, smokers with type 2 DM); and control (n = 25, non-diabetic non-smokers). Two subgingival biofilm samples from healthy sites (probing depth and clinical attachment level ≤3 mm and no bleeding) and 2 from diseased sites (probing depth and clinical attachment level ≥5 mm and bleeding on probing) were analyzed by quantitative polymerase chain reaction for Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Eubacterium nodatum, Parvimonas micra, Fusobacterium nucleatum ssp. and Prevotella intermedia.
There were no differences among groups in the mean counts of the bacterial species studied, considering all sampled sites (healthy plus diseased sites). There were also no differences among groups regarding the prevalence of any bacteria species in healthy and diseased sites (P > .05). The mean P. micra count was significantly higher in the healthy sites of both smoking groups, than in those of the control group (P < .05).
The subgingival levels and prevalence of the bacterial species studied are not significantly different in subjects with chronic periodontitis presenting DM, smokers or smokers with DM. In addition, DM and smoking, jointly and individually, do not considerably affect the subgingival levels of target periodontal pathogens in patients with chronic periodontitis.
理解糖尿病患者(DM)、吸烟者或 DM 合并吸烟者的龈下微生物群组成的相似和差异,是为牙周炎高危人群开发特定治疗方法的重要步骤。因此,本研究旨在比较 DM 和吸烟对慢性牙周炎患者龈下关键牙周致病菌水平和流行率的联合和单独影响。
将 100 名患有广泛性慢性牙周炎的患者分为以下组之一:DM(n=25,2 型糖尿病非吸烟者);S(n=25,非糖尿病吸烟者);SDM(n=25,2 型糖尿病合并吸烟者);和对照组(n=25,非糖尿病非吸烟者)。从健康部位(探诊深度和临床附着水平≤3mm,无出血)和病变部位(探诊深度和临床附着水平≥5mm,探诊出血)各采集两个龈下生物膜样本,通过定量聚合酶链反应分析牙龈卟啉单胞菌、福赛斯坦纳菌、中间普氏菌、真杆菌、微小消化链球菌、核梭杆菌和中间普氏菌。
考虑所有采样部位(健康部位加病变部位),各组之间研究细菌的平均计数无差异。在健康和病变部位,各组之间任何细菌的流行率也无差异(P>.05)。与对照组相比,两个吸烟组的健康部位真杆菌的平均计数明显更高(P<.05)。
患有慢性牙周炎的 DM 患者、吸烟者或 DM 合并吸烟者的龈下细菌种类的水平和流行率没有显著差异。此外,DM 和吸烟联合或单独使用,对慢性牙周炎患者的目标牙周致病菌的龈下水平没有显著影响。